The gap between those two positions pharmaceutical efficacy framing on one side, unsubstantiated supplement claims on the other is where a specific category is now forming
Youve probably seen the headlines: Ozempic linked to suicidal thoughts. Heres what the evidence actually shows: A 2025 meta-analysis in JAMA Psychiatry found no increased risk of depression or suicidality with GLP-1 medications versus placebo across multiple large trials
Trauma, sepsis and wound healing The metabolic process in trauma and sepsis includes greatly accelerated proteolysis and resulting protein loss in skeletal muscle [94]
CMS materials indicate the Bridge is aimed at beneficiaries prescribed these drugs for weight management who would not otherwise have access through Part D, and that people whose diagnoses are already coverable under Part D moderate to severe obstructive sleep apnea, noncirrhotic MASH with moderate to advanced fibrosis, or type 2 diabetes are handled through their existing benefit instead
4 For many people, improving those basics can support better appetite control, steadier energy, and healthier weight management